BD to Build $200 Million Manufacturing Facility in Spain

Pharmaceutical Technology Editors

BD’s new high-tech manufacturing facility in Zaragoza, Spain, will create up to 600 jobs by 2030.

BD (Becton, Dickinson and Company), a US-based medical technology company, announced on May 18, 2021 that it plans to build a €165 million (USD$200 million) high-tech manufacturing facility in Zaragoza, Spain, that will create up to 600 jobs by 2030.

The new site will initially house a workforce of 150 people in an area of 8000 m2 (86,000 ft2), with the numbers eventually rising to 600 people in an area of 30,000 m2 (323,000 ft2) by 2030, BD said in a company press release. Construction of the fully-digital, eco-efficient site will begin in late 2021, making it the fourth BD manufacturing site in Spain.

"BD's new plant in Zaragoza will produce drug delivery devices, primarily for pharmaceutical companies that supply the European market with drugs in prefillable syringes, such as vaccines and other biologic drugs," said Eric Borin, worldwide president of BD Pharmaceutical Systems, in the press release. "This new plant will also add needed capacity to support major vaccination campaigns, such as the one currently taking place in response to the COVID-19 pandemic."

Source: BD